» Articles » PMID: 37761907

Molecular Genetic Analysis of Russian Patients with Coagulation Factor FVII Deficiency

Overview
Journal Genes (Basel)
Publisher MDPI
Date 2023 Sep 28
PMID 37761907
Authors
Affiliations
Soon will be listed here.
Abstract

Coagulation factor VII (proconvertin) is one of the proteins starting the blood coagulation cascade. Plasma FVII concentration is regulated by different factors. A low level of FVII could also be a result of FVII deficiency (MIM# 227500), the rare autosomal recessive inherited disease caused by pathogenic variants in the gene. The aim of this study was to describe a mutation spectrum of the gene and genotype-phenotype relationship in patients with FVII deficiency in Russia for the first time. We studied the primary structure of the gene of 54 unrelated patients with FVII deficiency by direct Sanger sequencing. Pathogenic variants in the gene were detected in 37 (68.5%) of them. We identified 24 different mutations located mostly in the serine protease domain. Five pathogenic variants had never been reported before. A major mutation in the Russian population was c.1391delC (p. Pro464Hisfs*32), linked with rs36209567 and rs6046 functional polymorphisms, that is widely distributed in East Europe. As in other countries, the genotypes poorly correlated with the severity of clinical manifestations but were quite well associated with FVII levels. Minor alleles of functional polymorphisms rs510335, rs5742910, rs561241, rs36209567, and rs6046 could also participate in the genotype and influence FVII levels.

References
1.
Ken-Dror G, Drenos F, Humphries S, Talmud P, Hingorani A, Kivimaki M . Haplotype and genotype effects of the F7 gene on circulating factor VII, coagulation activation markers and incident coronary heart disease in UK men. J Thromb Haemost. 2010; 8(11):2394-403. PMC: 3226948. DOI: 10.1111/j.1538-7836.2010.04035.x. View

2.
Fromovich-Amit Y, Zivelin A, Rosenberg N, Tamary H, Landau M, Seligsohn U . Characterization of mutations causing factor VII deficiency in 61 unrelated Israeli patients. J Thromb Haemost. 2004; 2(10):1774-81. DOI: 10.1111/j.1538-7836.2004.00921.x. View

3.
Shihab H, Gough J, Cooper D, Stenson P, Barker G, Edwards K . Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models. Hum Mutat. 2012; 34(1):57-65. PMC: 3558800. DOI: 10.1002/humu.22225. View

4.
Carew J, Pollak E, High K, Bauer K . Severe factor VII deficiency due to a mutation disrupting an Sp1 binding site in the factor VII promoter. Blood. 1998; 92(5):1639-45. View

5.
van t Hooft F, Silveira A, Tornvall P, Iliadou A, Ehrenborg E, Eriksson P . Two common functional polymorphisms in the promoter region of the coagulation factor VII gene determining plasma factor VII activity and mass concentration. Blood. 1999; 93(10):3432-41. View